Vascular endothelial cells line the circulatory system, forming the interface between the blood and the underlying vessel wall and tissue spaces. In this anatomic location, the endothelium serves as the """"""""gateway"""""""" to the tissues for blood cells and macromolecules. It is my hypothesis that endothelial cell surface proteins play a role in binding and transendothelial migration of blood elements and further that alterations of endothelial cell surface proteins will produce changes in blood cell adhesion and entrance into the tissue spaces. The proposed research focuses upon endothelial cell surface proteins that are important for interactions with lymphocytes and in the development of a cell-mediated immunological reaction. Proteins known to be involved in T lymphocyte recognition of target tissues, including both major histocompatibility complex (MHC) antigens and non-MHC proteins, will be studied in cultured human vascular endothelial cells by immunochemical, biochemical and molecular biological approaches. The actions of gamma interferon, a T lymphocyte secreted mediator protein, upon cultured human endothelium will also be studied. In previous work, it was found that gamma interferon does in fact modulate the phenotype of cultured endothelial cells, and the extent of interferon-induced changes will now be studied. These experiments will use gamma interferon produced from a recombinant gene and thus free of all other human T cell mediators. Biochemical and immunochemical methods will be used to analyze changes in surface membrane and extracellular matrux (basement membrane) proteins of endothelial cells modulated by gamma interferon. In addition, fluorescence microscopy and fluorescence photobleach recovery methods will be used to study changes in the arrangement of endothelial surface and cytoskeletal proteins induced by gamma interferon. Finally, structural analysis of interferon-responsive proteins of functional importance will be undertaken. The objective of this proposal is to understand the mechanism of vascular endothelial interactions with lymphocytes (and eventually other blood elements) at the level of protein structure. Such an understanding may lead to new therapies in conditions such as autoimmunity, vasculitis, allograft rejection and other """"""""altered"""""""" endothelium sequelae including atherosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL036003-02
Application #
3350458
Study Section
Molecular Cytology Study Section (CTY)
Project Start
1985-07-01
Project End
1987-06-30
Budget Start
1986-07-01
Budget End
1987-06-30
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Pierce, Richard W; Merola, Jonathan; Lavik, John Paul et al. (2017) A p190BRhoGAP mutation and prolonged RhoB activation in fatal systemic capillary leak syndrome. J Exp Med 214:3497-3505
Al-Lamki, Rafia S; Wang, Jun; Yang, Jun et al. (2016) Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinoma. Oncotarget 7:24111-24
Abrahimi, Parwiz; Qin, Lingfeng; Chang, William G et al. (2016) Blocking MHC class II on human endothelium mitigates acute rejection. JCI Insight 1:
Al-Lamki, R S; Lu, W; Manalo, P et al. (2016) Tubular epithelial cells in renal clear cell carcinoma express high RIPK1/3 and show increased susceptibility to TNF receptor 1-induced necroptosis. Cell Death Dis 7:e2287
Clark, Paul R; Kim, Richard K; Pober, Jordan S et al. (2015) Tumor necrosis factor disrupts claudin-5 endothelial tight junction barriers in two distinct NF-?B-dependent phases. PLoS One 10:e0120075
Abrahimi, Parwiz; Chang, William G; Kluger, Martin S et al. (2015) Efficient gene disruption in cultured primary human endothelial cells by CRISPR/Cas9. Circ Res 117:121-8
Wang, Jun; Al-Lamki, Rafia S; Zhu, Xinwang et al. (2014) TL1-A can engage death receptor-3 and activate NF-kappa B in endothelial cells. BMC Nephrol 15:178
Pober, Jordan S; Sessa, William C (2014) Inflammation and the blood microvascular system. Cold Spring Harb Perspect Biol 7:a016345
Kluger, Martin S; Clark, Paul R; Tellides, George et al. (2013) Claudin-5 controls intercellular barriers of human dermal microvascular but not human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol 33:489-500
Al-Lamki, Rafia S; Lu, Wanhua; Wang, Jun et al. (2013) TNF, acting through inducibly expressed TNFR2, drives activation and cell cycle entry of c-Kit+ cardiac stem cells in ischemic heart disease. Stem Cells 31:1881-92

Showing the most recent 10 out of 82 publications